| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 6e-06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |